Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.89 +0.33 (+0.45%)
As of: Oct 20, 2026 · 2:06 PM EDT

Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013)

Updated

Ani Pharmaceuticals' Construction in Progress was $197,948 in Q3 2013, up 12.3% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013) Analysis & Trends

At the end of FY2012, Construction in Progress at Ani Pharmaceuticals came in at $208,069.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,149.93 Bn 1,118.52 Bn 19.71 Bn -
2 Johnson & Johnson 625.23 Bn 543.75 Bn 17.26 Bn -
3 AbbVie 512.30 Bn 485.41 Bn 12.70 Bn -
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn -
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn -
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn -
7 Amgen 235.12 Bn 190.52 Bn 7.24 Bn -
8 Gilead Sciences 194.40 Bn 168.60 Bn 6.22 Bn -
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -
10 Ani Pharmaceuticals 1.54 Bn 322.62 Mn 165.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 197,948.00
Jun 30, 2013 176,276.00
Dec 31, 2012 208,069.00
API Access

Ani Pharmaceuticals Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ANIP&period=max&api_key=YOUR_API_KEY